Avita Medical | 1811094D - Zinsaufwendungen Für Schuld

Aktienkurs
1.30
Täglich Wechseln
0.10 8.33%
Monatlich
-5.11%
Jährlich
-52.90%
Q2 Prognose
1.05




Zinsaufwendungen Für Schuld Veränderung Datum
Accuray USD 2.88M 72K 2024-12
Celltrion KRW 19B 1.96B 2025-06
Clinuvel Pharmaceuticals AUD 2.49M 51.97K 2025-06
Cochlear AUD 6.3M 3.65M 2025-12
CSL USD 215M 111M 2025-12
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 30M 2025-12
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Mayne Pharma AUD 1.2M 50K 2024-06
Medical Developments International AUD 18K 3K 2025-06
Nanosonics AUD 779K 94K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Paradigm Biopharmaceuticals AUD 1000 3K 2025-06
Pharma Mar EUR 117K 1.24M 2025-09
Polynovo AUD 506K 130K 2025-06
PYC Therapeutics AUD 17K 11K 2025-06
Qiagen NV USD 10.14M 1.92M 2025-12
Ramsay Health Care AUD 300.6M 15.5M 2025-12
ResMed USD 775K 886K 2024-12
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Telix Pharmaceuticals AUD 7.62M 11.22M 2025-12
Tilray USD 6.7M 2.73M 2025-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06